Key Market Indicators
By 2026, Iran is expected to reach 40% in coverage of HIV/AIDS treatment for those living with the virus. This growth of 3.9% year-on-year from the 31% coverage in 2021 is an increase of 15.6% since 2011. In 2021, Iran was ranked 126, with Djibouti in the lead at 31%. Cape Verde, Latvia, and Zimbabwe followed in positions 2, 3, and 4, respectively. For those aged 0-14, the estimated prevalence of HIV/AIDS in Iran is expected to reach 812 units in 2026, a 1.2% year-on-year growth from 753 units in 2021. This is a 1.8% increase since 1995. In 2021, Iran was ranked 62, with Honduras in the lead at 753 units. Nigeria, Mozambique, and Tanzania followed in positions 2, 3, and 4, respectively.
